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1. Introduction 
 Insomnia is the most common sleep disorder. It is also, together with pain and fatigue, the 
most common ailment among all of us. Insomnia can be a standalone diagnostic category, 
but just like fever or pain, can be a symptom of another disease, either somatic or mental. 
Though insomnia is a prevalent condition in our society, both doctors and patients are 
lacking in the knowledge about it. There are also no generally accepted standards of 
treatment, especially the pharmacological. 
Sleepless nights happen to everyone. Many scientists and most of the society think of 
insomnia as a natural reaction of the organism to tension or noise. The popular opinion is 
right. It is natural - this condition is called short-term insomnia or adjustment insomnia 
(according to ICSD – International Classification of Sleep Disorders; AASM, 2005) - when 
the sleeplessness is related to stress and anxiety. But as the researches show - the short-term 
insomnia can easily transform into a chronic condition. Numerous epidemiological studies 
have discovered that about 30% of the world's population, including more than 50% of 
people older than 60 and almost 20% of those younger declare sleep disorders. One third of 
these cases can be qualified as chronic insomnia (Ohayan, 1997; Szelenberger & Skalski 
1999). 
There are many explanations of such a distinctive increase in number of complaints of 
insomnia, as the natural adjustment to the changing world, lifestyle, circadian rhythm 
disorders or as a syndrome of worsening physical and mental state of society. Although 
some facts are hard to disagree with, it is worth to mention that some researchers say it does 
not make much sense to talk about insomnia in the categories we got used to. They believe 
sleep is just one of our basic needs - we sleep to deal with fatigue as we eat to deal with 
hunger. They compare insomnia to obesity - both result from an inappropriate lifestyle. 
Eating too much results in obesity. Being lazy and having exaggerated expectations of the 
sleep result in insomnia. Authors of these ideas underpin their concepts with researches of 
animals' sleep where the animals living in natural conditions having to fight for their 
survival sleep distinctively shorter than the ones living in safety of a laboratory. In 
conclusion, we complain of insomnia because we are wealthy, safe and have too much spare 
time we want to fill with sleeping (Anderson & Horne, 2008). 
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Can the modern science help us to resolve these dilemmas? In the following book chapter 
we will try to resolve problems associated with diagnosing and treating insomnia and will 
try to present practical solutions for sleeplessness. 
2. Insomnia - definitions, diagnostic criteria 
What is insomnia? A basic definition of insomnia can be easily derived from what we have 
describe before. Insomnia is a subjective feeling of not getting enough sleep in terms of its 
length and quality together with its consequences, such as being unproductive and in bad 
mood during daytime. 
Types of insomnia: 
Insomnia is generally divided into primary and secondary insomnia. Primary insomnia 
appears for no apparent reason, secondary is related to another diseases. Another popular 
criteria are how long insomnia persists. Transient insomnia lasts for a few days to a week, 
acute insomnia (up to one month) and chronic insomnia (more than one month) (NIMH, 
1984).  
2.1 Criteria of diagnosing insomnia 
The following are the most common and accepted definitions and diagnostic criteria of 
insomnia according to ICD-10, DSM-IV-TR and ICSD-2, (WHO 1992; APA, 2000; AASM, 
2005). 
ICD-10 diagnosis code F51 (WHO, 1992) 
Sleep disorders not due to a substance or known physiological condition 
F51.0 Nonorganic insomnia. A condition of unsatisfactory quantity and/or quality of sleep, 
which persists for a considerable period of time, including difficulty falling asleep, difficulty 
staying asleep, or early final wakening. Insomnia is a common symptom of many mental 
and physical disorders, and should be classified here in addition to the basic disorder only if 
it dominates the clinical picture. Excludes: insomnia (organic) (G47.0 ) 
ICD-10 diagnosis code G47 (WHO, 1992) 
Sleep disorders 
G47.0 Disorders of initiating and maintaining sleep [insomnias] 
ICD-10 diagnostic criteria for non-organic insomnia 
a. A complaint of excessive daytime sleepiness or sleep attacks or prolonged transition to 
the fully aroused state upon awakening (sleep drunkenness) (not accounted for by an 
inadequate amount of sleep).  
b. This sleep disturbance occurs nearly every day for at least one month or recurrently for 
shorter periods of time and either causes marked distress or interference with personal 
functioning in daily living.  
c. Absence of auxiliary symptoms of narcolepsy (cataplexy, sleep paralysis, hypnagogic 
hallucinations) or of clinical evidence for sleep apnea (nocturnal breath cessation, 
typical intermittent snorting sounds, etc.). 
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d. Absence of any known causative organic factor, such as a neurological or other medical 
condition, psychoactive substance use disorder or a medication. 
DSM-IV-TR diagnostic criteria for primary insomnia (APA, 2000) 
a. The predominant complaint is difficulty initiating or maintaining sleep, or 
nonrestorative sleep, for at least 1 month.  
b. The sleep disturbance (or associated daytime fatigue) causes clinically significant 
distress 
c. The sleep disturbance does not occur exclusively during the course of narcolepsy, 
breathing-related sleep disorder, circadian rhythm sleep disorder, or parasomnia. 
d. The disturbance does not occur exclusively during the course of another mental 
disorder (e.g., major depressive disorder, generalized anxiety disorder, a delirium). 
e. The disturbance is not due to the direct physiological effects of a substance. 
Diagnostic criteria for insomnia (ICSD-2, 2005) 
a. A complaint of difficulty initiating sleep, difficulty maintaining sleep, or waking up too 
early, or sleep that is chronically nonrestorative or poor in quality. 
b. The above sleep difficulty occurs despite adequate opportunity and circumstances for 
sleep. 
c. At least one of the following forms of daytime impairment related to the nighttime 
sleep difficulty is reported by the patient: 
1. Fatigue or malaise; 
2. Attention, concentration, or memory impairment; 
3. Social or vocational dysfunction or poor school performance; 
4. Mood disturbance or irritability; 
5. Daytime sleepiness; 
6. Motivation, energy, or initiative reduction; 
7. Proneness for errors/accidents at work or while driving; 
8. Tension, headaches, or gastrointestinal symptoms in response to sleep loss; and 
9. Concerns or worries about sleep. 
In conclusion, according to the diagnostic criteria listed above, we need the following 
symptoms to diagnose insomnia: 
1. Presence of sleep disorders (difficulty falling asleep, difficulty staying asleep, or early 
wakening) during the better part of the night and persistent for at least one month 
2. Worsened daytime functioning caused by these sleep disorders. 
ICD-10 classifications also divide insomnia into different forms 
ICD-10 sleep disorders 
- organic insomnia 
- nonorganic insomnia 
DSM-IV diagnoses of sleep disorders 
- Primary sleep disorders 
- Dyssomnias 
- Primary insomnia 
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- Sleep disorders related to another mental disorder 
- Insomnia related to another mental disorder 
- Secondary sleep disorders due to an Axis III condition 
- Insomnia type 
- Substance-induced sleep disorders 
- Insomnia type 
ICSD-2 sleep disorder categories - insomnias (specific disorders) 
Adjustment (acute) insomnia 
The essential feature of this disorder is the presence of insomnia in association with an 
identifiable stressor, such as psychosocial, physical, or environmental disturbances. The 
sleep disturbance has a relatively short duration (days-weeks) and is expected to resolve 
when the stressor resolves. 
Psychophysiological insomnia 
The essential features of this disorder are heightened arousal and learned sleep-preventing 
associations. Arousal may be physiological, cognitive, or emotional, and characterized by 
muscle tension, “racing thoughts,” or heightened awareness of the environment. Individuals 
typically have increased concern about sleep difficulties and their consequences, leading to a 
“vicious cycle” of arousal, poor sleep, and frustration. 
Paradoxical insomnia 
The essential feature of this disorder is a complaint of severe or nearly “total” insomnia that 
greatly exceeds objective evidence of sleep disturbance and is not commensurate with the 
reported degree of daytime deficit. Although paradoxical insomnia is best diagnosed with 
concurrent PSG and self-reports, it can be presumptively diagnosed on clinical grounds 
alone. To some extent, “misperception” of the severity of sleep disturbance may characterize 
all insomnia disorders. 
Idiopathic insomnia 
The essential feature of this disorder is a persistent complaint of insomnia with insidious onset 
during infancy or early childhood and no or few extended periods of sustained remission. 
Idiopathic insomnia is not associated with specific precipitating or perpetuating factors. 
Insomnia due to mental disorder 
The essential feature of this disorder is the occurrence of insomnia that occurs exclusively 
during the course of a mental disorder, and is judged to be caused by that disorder. The 
insomnia is of sufficient severity to cause distress or to require separate treatment. This 
diagnosis is not used to explain insomnia that has a course independent of the associated 
mental disorder, as is not routinely made in individuals with the “usual” severity of sleep 
symptoms for an associated mental disorder. 
Inadequate sleep hygiene 
The essential feature of this disorder is insomnia associated with voluntary sleep practices 
or activities that are inconsistent with good sleep quality and daytime alertness. These 
practices and activities typically produce increased arousal or directly interfere with sleep, 
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and may include irregular sleep scheduling, use of alcohol, caffeine, or nicotine, or engaging 
in non-sleep behaviors in the sleep environment. Some element of poor sleep hygiene may 
characterize individuals with other insomnia disorders. 
Insomnia due to a drug or substance 
The essential feature of this disorder is sleep disruption due to use of a prescription 
medication, recreational drug, caffeine, alcohol, food, or environmental toxin. Insomnia may 
occur during periods of use/exposure, or during discontinuation. When the identified 
substance is stopped, and after discontinuation effects subside, the insomnia is expected to 
resolve or substantially improve. 
Insomnia due to medical condition 
The essential feature of this disorder is insomnia caused by a coexisting medical disorder or 
other physiological factor. Although insomnia is commonly associated with many medical 
conditions, this diagnosis should be used when the insomnia causes marked distress or 
warrants separate clinical attention. This diagnosis is not used to explain insomnia that has a 
course independent of the associated medical disorder, and is not routinely made in 
individuals with the “usual” severity of sleep symptoms for an associated medical disorder. 
Insomnia not due to substance or known physiologic condition, unspecified; physiologic 
(organic) insomnia, unspecified 
These two diagnoses are used for insomnia disorders that cannot be classified elsewhere but 
are suspected to be related to underlying mental disorders, psychological factors, behaviors, 
medical disorders, physiological states, or substance use or exposure. These diagnoses are 
typically used when further evaluation is required to identify specific associated conditions, 
or when the patient fails to meet criteria for a more specific disorder. 
Judging the categories presented above from a practical and clinical point of view we have 
to admit that none of them is sufficient for diagnosing and treatment of insomnia. ICD-10 
divides insomnia into nonorganic and organic form which is a big simplification while ICSD 
proposes a way too complicated categorizing which does not make it useful in everyday 
practice. Definitely, the most useful of all systems is the DSM-IV-TR classification system, 
dividing insomnia into 4 categories: 
- Primary insomnia 
- Insomnia related to another mental disorder 
- Insomnia due to medical disorders 
- Substance-induced insomnia 
We estimate that this classification is the most useful and helpful in diagnosis and treatment 
of insomnia. 
2.2 Practical categorization of insomnia 
Because other chapters of this book encompasses a complex analysis of secondary insomnia, in 
the following part we are going to focus on the pure-form primary insomnia, described also as 
nonorganic insomnia, primary insomnia or psychophysiological insomnia in different 
diagnostic criteria. When diagnosing a new patient it is very important to properly assess the 
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problem. We have to know if the troubles a patient declares meet criteria of insomnia. Based 
on carefully collected medical history about behaviors related to sleep and sleep diary analysis 
we often see that many patients, especially the older ones, spend 8 to 10 hours daily in bed, 
sleeping only 5 to 7 hours in that time. As a result, though they sleep well, their time spent in 
bed includes a few additional hours of WASO (Wakefulness After Sleep Onset). Such a state 
can hardly be classified as a real insomnia; though a patient does not fulfill their entire need 
for sleep, it has to be said that patient’s expectations of sleeping through 8 hours in the night 
without interruptions are not realistic. Sleep disorder like this cannot be classified as insomnia; 
we can call them inadequate sleep hygiene or unrealistic expectations of sleep. Treatment of 
these disorders should not be done by fulfilling patient’s expectations, but by making them 
more realistic. A second group of sleep disorders often wrongly classified as insomnia 
concerns mainly young people complaining about sleepiness during daytime, fatigue and 
troubles with waking up in the morning. But the analysis of their behaviour and sleep diary 
shows that usually because of work, learning or play almost every night they sleep less than 
other in the same age group. Such a state called sleep deprivation rather not insomnia. 
After diagnosing the real insomnia, the most important part is determining how long it 
persists. The traditional categorizing divides insomnia into: 
- Transient insomnia - a few days 
- Acute insomnia - up to 4 weeks 
- Chronic insomnia - longer than one month (NIMH, 1984). 
Transient insomnia lasts for a few days to a week, acute insomnia (up to one month) and 
chronic insomnia (more than one month). Transient and acute insomnias are usually related 
to some kind of trigger (stress, noise, pain). Chronic insomnia can be related to another 
sickness but more often, it is caused by so - called perpetuating factors which cause 
insomnia to remain even when the primary causation of it is gone. We can conclude that 
while the short-term insomnia is usually secondary, the chronic one becomes primary. 
2.3 Insomnia diagnosis 
Because only 1 / 3 of patients reported their sleep problems to physician (Szelenberger & 
Skalski, 1999, Pentor 2000), undoubtedly the first and most important task in the diagnostic 
process is to find patients with sleep disorders. It is therefore recommended that the 
questions about the quality of sleep and mood in the morning are a regular part of every 
medical interview, in almost every medical specialty. Patients with insomnia should go 
immediately to their general practitioners and begin the correct treatment. 
The main diagnostic tool is the interview focused on sleep, respectively, accompanied by any 
further diagnostic tests for determining somatic or psychiatric causes of insomnia (Table 1).  
2.4 Development of chronic insomnia 
Modern views on etiology and pathogenesis of insomnia show correlation between various 
biological, medical and environmental factors in creating insomnia and causing it to persist. 
These factors can be divided into 3 groups – 3P (Spielman, 1986): 
Predisposing factors - being prone to insomnia, biological grounds like personality, 
maintaining circadian rhythm, age, genetics. 
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I. Interview schedule:  
1st Determine the type and nature of sleep disorders: 
2nd Disease and associated factors: 
- Somatic diseases and medications  
- Psychosocial stress  
- Mood disorders  
3rd Sleep before the onset of symptoms: 
- The quality of sleep before the onset of insomnia  
- The earlier episodes of insomnia  
- Other sleep disorders  
- Reaction to treatment  
4th Sleep hygiene: 
- Time of lie down and getting up from bed  
- Sleep on weekdays and holidays  
- Variable working hours in the day and night, shift work 
- Naps during the day  
- Physical exercise habits and lifestyle  
- Consumption of coffee, alcohol and other drugs 
5th Information from bed partner: 
- Snoring and irregular breathing  
- Movements during sleep  
- Evaluation of sleep length and quality of patient  
- Changes in mood and behavior of the patient  
II. Somatic Research, depending on the patient's complaints focused on the search:  
1st rheumatic  
2nd respiratory and ENT  
3rd cardiovascular  
4th renal  
5th neurological  
6th cancer  
7th gastrological  
III. Psychiatric and psychological assessment:  
1st on the basis of conversation  
- Behavior changes  
- Mood changes  
- Anxiety  
- Psychosocial stress situations  
- Excessive preoccupation with his dream  
2nd based on scales, e.g.  
- Beck Depression Scale (self)  
- Hamilton Depression Rating Scale  
- Hamilton anxiety scale  
- Dementia assessment scale (Mini Mental State)  
- MMPI personality assessment scale  
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3rd eventual referral to a psychologist or psychiatrist  
IV. Sleep monitoring studies:  
1st polysomnographic study 
2nd actigraphic registration 
3rd study MSLT (Multiple Sleep Latency Test allows an objective assessment of excessive 
sleepiness) 
Table 1. Examination scheme of patients with sleep disorders 
Precipitating (Triggers) factors causing sleep interruptions directly - environmental, 
adaptive, medical 
Perpetuating factors - drugs abuse, improper sleep hygiene, exaggerated expectations of 
sleep, the fear of insomnia - often create a vicious circle of insomnia. 
There is more and more evidence that people with insomnia are constantly in the state of so-
called hyperarousal. Many of them are less sleepy during daytime, which can be measured 
by studying duration of their naps. These people also have significantly increased 
metabolism level during the whole 24 hours. Consequently, assumptions have been made 
that in patients with chronic insomnia the main and most common problem is the excessive 
arousal responsible both for poor functioning during daytime and problems with sleep at 
night. People with insomnia have increased ACTH level and raised cortisol secretion and 
lowered inhibitory neurotransmitter GABA level. (Bonnet & Arand, 1997; Perlis et al. 1998; 
Vgontzas et al. 1998; Winkelman et al., 2008) 
Knowledge of the mechanisms listed above is extremely important for successful treatment 
requiring focus on various aspects of insomnia. Contemporary rules say that the treatment 
should be commenced with the occurrence of the very first symptoms of insomnia to 
quickly eliminate the causes and avoid perpetuating mechanisms. 
3. Treatment of insomnia 
When to start with treatment of insomnia, how and by whom should it be treated? 
In any case, if sleep problems persist for longer than 2-3 weeks and begin to negatively 
impact on functioning during the day, be sure to seek medical advice. 
In the case of short-term insomnia, especially in those predisposed to insomnia, it is 
necessary to take treatment as soon as possible. It is usually sufficient administration of 
temporary hypnotic drug. The patient places the sleeping pill, near the bed and reaches for 
it when can not sleep. This treatment protects the patient against the occurrence of factors 
perpetuate insomnia and prevents against the development of chronic insomnia. 
In chronic insomnia administration of hypnotics is neither effective nor consistent with the 
principles of administration of hypnotics (no longer than 2-4 weeks). In addition, 
perpetuates and worsening course of insomnia and increases the risk of dependence on 
hypnotics. The primary method of treatment for chronic insomnia is behavioral therapy. 
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3.1 Non-pharmacological treatment of insomnia 
There are numerous methods of non-pharmacological treatment of insomnia. They include:  
- - information on the sleep hygiene principles,  
- - stimulus control,  
- - sleep restriction,  
- - relaxation techniques,  
- - feedback,  
- - cognitive therapy,  
- - “chronotherapy”,  
- - phytotherapy (Morin, 1999; Yang, 2005; Schutte-Rodin, 2008). 
3.1.1 Behavioral techniques 
3.1.1.1 Sleep hygiene education 
The sleep hygiene principles include: refraining from naps during the day; getting to sleep 
and getting up at the same time; restraining or giving up consumption of caffeine, alcohol 
and nicotine; avoiding physical activities shortly before moving to bed, staying away of any 
emotional arousal before bedtime, ensuring quiet environment and comfortable temperature 
in a bedroom, removing clocks from a bedroom (Hauri & Fisher, 1986). 
3.1.1.2 Sleep restriction 
A sleep restriction means for the patient being in bed no longer than usually sleeps at night, 
according to his subjective assessment (for example, by sleep diary). As the sleep's length is 
usually underestimated, the patient will partially deprive his sleep, reducing at the same 
time the number of awakenings the following night (Spielmann et al. 1987). 
3.1.1.3 Stimulus control therapy 
Stimulus control technique aims to restrict the bedroom and the bed for a sleep only. 
Reading, eating and watching television in bed is prohibited. The patient should go to bed 
only when feeling sleepy. If a sleep does not come within the next ten minutes, he has to get 
up, go to another room and return only when feeling sleepy. An alarm clock should be set 
always at the same time, regardless of a sleep's length. The patient also has to refrain from 
naps during the day (Bootzin et al. 1991). 
3.1.2 Cognitive therapy 
Insomnia-related concerns increase insomnia, causing excitation and further exacerbate 
sleep problems. It has been proven that the erroneous beliefs and attitudes toward sleep are 
associated with symptoms of insomnia. Changing negative thoughts can reduce concerns 
about the lack of sleep and break the vicious circle leading to excitation and insomnia.  
Common incorrect beliefs about sleep can be classified into five categories:  
1. misunderstanding of insomnia's causes,  
2. seeking incorrect or exaggerated insomnia consequences  
3. unrealistic expectations of sleep,  
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4. limited perception of control over sleep  
5. belief that sleep could be predictable. 
Incorrect beliefs about sleep can be corrected by educating patients about the principles of 
the sleep hygiene. The aim of the cognitive therapy is the recognition by the patient that he 
can cope with the problem of insomnia. (Morin et al. 1999; 2002).  
For several years, in Warsaw Sleep Disorders Clinic we regularly conduct CBT group 
therapy (six sessions, every week, number of patients 6-10). Our findings confirmed the high 
efficacy of the CBT therapy. CBT-I produced sustained self-reported improvement in 
nocturnal sleep and daytime functioning (Fornal-Pawłowska et al., 2010). After 3 months, 
insomniacs did not differ from good sleepers in sleep quality and social functioning ratings 
(Fig. 1 and 2). 
 
87,9 min. 87,8 min.
48,7 min. 48,1 min.
38,9 min. 35,8 min.
SLEEP LATENCY WAKE AFTER SLEEP
ONSET  
Fig. 1. Changes in sleep parameters: sleep latency and WASO, at baseline, post-treatment 
and the 3-month follow-up 
 
5,4 h 5,7 h
6,3 h
TOTAL SLEEP TIME   
Fig. 2. Changes in total sleep time at baseline, post-treatment and the 3-month follow-up 
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3.1.3 Summary of non-pharmacologic strategies 
For the past 10 years in our sleep disorders clinic in Warsaw CBT of insomnia has become a 
routine method of treatment for chronic insomnia. It consists of 6 sessions which take place 
once a week, in groups consisting of 6-10 people. In the following sessions, patients are 
educated about the physiology of sleep and sleep disorders. Then learn the next technique: 
education about sleep hygiene, sleep restriction, stimulus control, relaxation exercises, and 
finally cognitive therapy oriented at dysfunctional thoughts related to insomnia. In parallel, 
patients receive information about rational pharmacotherapy of insomnia, which is only 
occasional use of hypnotics (2-3 times a week) and possibly the use of low doses of 
antidepressant drugs or herbal medicines. The results so far are very promising (shown in 
the Figures above) and indicate that the CBT treatment of insomnia is currently the most 
effective treatment for chronic insomnia. 
3.2 Pharmacological treatment of insomnia 
Drug treatment is indicated for patients as short-term relief of symptoms of insomnia but is 
insufficient for long-term management of chronic insomnia. In combination with cognitive-
behavioral therapy, it gives the best results in improving the quality of sleep. 
(Riemann&Perlis, 2009; Saddichha, 2010). 
3.2.1 Benzodiazepine Receptor Agonists (BZD or newer BzRAs) 
The most widely used method for insomnia is to administer benzodiazepine receptor 
agonists (Yang, 2005; Schutte-Rodin, 2008). This group includes all the traditional 
benzodiazepines (BZD) and hypnotics new generation (benzodiazepine receptor agonists - 
BzRAs) - zolpidem, zopiclone and zaleplon.  
3.2.1.1 Benzodiazepines 
The selection of a specific benzodiazepine agonist should be performed in accordance with 
the knowledge of its pharmacokinetics. When changing the medication, be sure to 
equivalent doses of different preparations. 
Objective results of treatment with hypnotics are small: latency is shortened by 15 minutes 
and total sleep time increased by about 30 minutes. Benzodiazepines do not improve sleep 
quality. Rapidly lose their hypnotic effect, sometimes after a few days. Dependence 
develops after regular ingestion of several weeks. Prevention of tolerance and addiction is 
the administration of hypnotics no more than 2-3 times a week and the lowest dose, repeat 
the drug at intervals of less than four times the value of its half-life leading to accumulation 
(Walsh et al. 2000; Hajak et al. 2002; Perlis, 2004). 
3.2.1.2 Non-benzodiazepine hypnotics 
In comparison with traditional BZD new generation hypnotic drugs appear to be a major 
step forward. Zolpidem and zaleplon are selective benzodiazepines receptor agonist. 
Because of their selective action on the omega-1 receptor, subclass of BZD receptors they do 
not affect cognition, memory and motor function. Zolpidem, zopiclone, and zaleplon 
rapidly absorbed and have a short biological half-life. This is important because residual 
symptoms the next day, that is, impairment of psychomotor skills and memory, depend on 
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the biological half-life time. It is believed that the new benzodiazepine receptor agonists 
hypnotics give less risk of tolerance and dependence. 
Need to be aware that in a patient with insomnia, hypnotic drug administration is only 
supportive care, relieving symptom of disease rather than treating disease.  
Of course, the effects of hypnotics may be helpful in the general treatment of insomnia, 
when once again "we teach" patients sleep. But leaving the patient without the 
comprehensive support reduces the effectiveness of treatment, and very easily lead to 
addiction 
3.2.2 Summarize the role of hypnotics in insomnia 
In the short-term insomnia: 
- Recognize as soon as possible insomnia and give patients a new generation of hypnotics 
(zolpidem, zopiclone, zaleplon), which may prevent in a patient developing in 
perpetuating factors 
- The best method is to put the sleeping pills near the bed and reaching for it, when the 
patient is waiting too long to fall asleep after laying to bed, or in the event of the night 
awakenings 
- Such way taking of sleeping pills will allow most patients with insomnia to avoid short-
term transition in chronic insomnia, and at the same time protect them from 
dependence on hypnotics. 
- The experiences of our everyday practice show that mere possession of an effective 
sleeping pills near the bed allows the patient to sleep better. 
In the chronic insomnia: 
- Do not chronic use of hypnotics (benzodiazepine receptor agonists), with daily use and 
must not be taken for more than 2 weeks. 
- They can be take longer, but only if they are used temporarily "as needed" which is 2 to 
3 times a week (or up to 10 times a month). 
- Sleeping pills can be used if the patient also use behavioral techniques. 
- Almost all patients after therapy, CBT, occasionally use sleeping pills, only a few times 
a month. Even if earlier abused benzodiazepines. 
3.2.3 Sedative low dose antidepressant (AD) 
In recent years, increasingly in the supportive treatment of insomnia is proposed to use 
the drugs from other groups deserve special attention and antidepressants, natural 
remedies, available without prescription (Thase, 1999; James & Mendelson 2004; Krystal et 
al. 2010).  
In clinical practice, in case of necessity of prolonged treatment of insomnia alternative to the 
sleeping pills are antidepressants with sedative-hypnotic properties. The most commonly 
used drugs of such a profile are Trazodone, Mianserin, Mirtazapine, Doxepin. It has been 
proven that improves sleep in people suffering from insomnia and increases the amount of 
SWS. Some tricyclic antidepressants (TCAs) are also strong action sleeping pills. However, 
due to non-selective effect, causing more side effects. 
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There is no fixed standard dosage in the treatment of insomnia, usually are used in low 
doses in comparison to those used in depression. (James & Mendelson 2004; Krystal et al. 
2010). 
In everyday practice, Warsaw Sleep Disorders Clinic doses fully sufficient as a "hypnotic", are: 
- mianserin 5 to 15 mg 
- trazodone 25 do 100 mg 
- mirtazapine 7,5 do 15 mg 
The above mentioned dose are the smallest as possible to achieve (the tablets can not be 
divided any more), it is possible that even lower doses might be effective. Such small doses 
are usually very well tolerated and, in addition antidepressants do not give a risk of 
addiction. The most common side effect of what we find in our patients the symptoms of 
restless leg syndrome (RLS), usually after mianserin, less frequently after trazodone. 
But even with such a small and safe doses should be avoided their chronic use, so that the 
patients do not used to falling asleep on the pills. Usually after a normalization of sleep and 
sleep hygiene correction also we recommend discontinuing medication. 
3.2.4 Over-the-counter agents 
In the insomnia is also used medicines available without prescription, such as melatonin, 
antihistamines and herbal medicines. These drugs are increasingly used (Montserrat 
Sanchez-Ortuno et al., 2009), but still is little systematic studies. From the few the available 
data it is estimated that natural remedies used from 4 to 18% of all people and from 30 to 
over 70% of those complaining of insomnia (Montserrat Sánchez-Ortuño et al., 2009; Sarris & 
Byrne, 2010; Salter & Brownie, 2010). So far performed too small amount of normal, placebo-
controlled studies to evaluate the effectiveness of drugs used without a prescription for 
insomnia. Published in the last year review of all available studies of natural drugs and 
methods used in insomnia indicate an advantage of preparations containing valerian and 
hops in the improvement of various parameters of sleep (Montserrat Sánchez-Ortuño et al., 
2009).  
3.2.5 The risk of dependence 
When discussing pharmacological treatment of insomnia can not ignore the problem 
dependence benzodiazepines. Experience our Sleep Disorders Clinic indicate that a large 
proportion of patients with chronic insomnia are more or less dependent on 
benzodiazepines. In a large part of patients, the existing dependence seems to be the 
primary cause of insomnia. In this case, the first stage of treatment is the gradual 
withdrawal of benzodiazepines and to manage the withdrawal symptoms. In the treatment 
of benzodiazepines dependence in patients with insomnia CBT therapy was very effective 
(Morin et al., 2004), also routinely used in our Warsaw Sleep Disorders Clinic. 
4. Summary 
The current rules establish that the treatment of insomnia should start right from the 
beginning of its occurrence, to avoid appearance of perpetuating factors - chronic insomnia 
development.  
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In the case of the diagnosis of transient or short-term insomnia, a basic method of treatment 
is usually administrating the right hypnotics and information on the sleep hygiene.  
In chronic insomnia, a basic treatment is cognitive-behavioral therapy (CBT), which can help 
pharmacologically by regular use of “sedative and hypnotic” antidepressant medication in 
the evening only "as needed" taking hypnotics drugs (no more than 2-3 times a week). 
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